We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.

CIRM grant will help expand patients’ access to UCLA clinical trials for stem cell, gene therapies



UCLA CTSI News Archive


The CIRM Grant will help the Alpha Stem Cell Clinic deliver clinical trials and strengthen health education, workforce development and community care initiatives.

A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-section of Los Angeles’ diverse population in potentially lifesaving medical research.

In part, the grant will fund the UCLA Alpha Stem Cell Clinic’s continued collaboration with the UCLA Clinical and Translational Science Institute, which supports more than 350 clinical trials at medical centers and community clinics throughout the region.

“Integrating the Alpha Stem Cell Clinic and Clinical and Translational Science Institute enables the university to build on the breadth and depth of investigators, support staff and infrastructure that already exist here,” said Dr. Noah Federman, a UCLA Health professor of pediatrics and orthopaedic surgery, and director of the Alpha Stem Cell Clinic. “Together, we’ll continue to focus on accelerating innovative stem cell and gene therapies to patients while meeting the basic health care needs of underserved communities.”

Read the full UCLA press release.